worldwide@absin.cn
  • Sign in or Register
    My account Recent orders Wish list Address management

    Sign out

  • Cart 0
    The latest additions

      0 items in total

      Subtotal $0.00

      Go to cart
    • English
      Chinese
    爱必信(absin)官网
    爱必信(absin)官网

    000000 Citations

    Home
    Products
    Promotions
    Resources
    Product ApplicationFAQsNewsCitationsElectronic DocumentsCalculation Tools
    About us
    Contact us
    worldwide@absin.cn
    • Sign in or Register
      My account Recent orders Wish list Address management

      Sign out

    • Cart 0
      The latest additions

        0 items in total

        Subtotal $0.00

        Go to cart
      • English
        Chinese
      爱必信(absin)官网
      爱必信(absin)官网

      000000 Citations

      Home
      Products
      Promotions
      Resources
      Product ApplicationFAQsNewsCitationsElectronic DocumentsCalculation Tools
      About us
      Contact us
      HomeProduct ApplicationLiterature Review: How DSS, Pertussis Toxin and Multiplex IHC Enabled a Systematic Dissection of Intestinal Inflammation in Science Advances
      Search

      Literature Review: How DSS, Pertussis Toxin and Multiplex IHC Enabled a Systematic Dissection of Intestinal Inflammation in Science Advances

      October 30, 2026

      Clicks:82

      Share:
      Share This on facebook
      Share This on twitter
      Share This on pinterest
      Share This on linkedin
      Share This on skype
      Share This on telegram
      Share This on whatsapp
      Share This on wechat

      Literature Review: How DSS, Pertussis Toxin and Multiplex IHC Enabled a Systematic Dissection of Intestinal Inflammation in Science Advances

      Toll-like receptor (TLR) signaling is a central hub of the innate immune response, yet whether it is directly regulated by gut microbiota-derived metabolites remained unresolved for years. On 10 July 2026, Science Advances published a study demonstrating that short-chain fatty acids (SCFAs) are sensed by p38α MAP kinase, leading to suppression of TLR signaling and alleviation of intestinal inflammation (Wu et al., Sci. Adv. 12, eaef1419, 2026). Three reagents played instrumental roles in this work: the DSS colitis model, pertussis toxin (PTX), and a multiplex immunohistochemistry (mIHC) detection kit. This review outlines the core application scenarios and experimental value of each.

      1. DSS (Dextran Sulfate Sodium) — The Gold-Standard Reagent for Colitis Induction

      Application in the study. The authors administered 3% (w/v) DSS to C57BL/6 mice in drinking water for 5 days to establish an acute colitis model. DSS treatment produced colon shortening, body weight loss and substantial infiltration of immune cells, including CD4+ T cells, CD8+ T cells, CD19+ B cells, macrophages and neutrophils. This model was then used to evaluate the therapeutic effect of propionate and butyrate.

      Why DSS?

      • Efficient and highly reproducible. DSS-induced colitis closely resembles human ulcerative colitis in histological features, clinical presentation, lesion location and cytokine profile.

      • Simple to administer. Induction is achieved through drinking water alone, without surgical intervention.

      • Extensively validated. Supported by well over a thousand publications, and applicable to mouse, rat and zebrafish models.

      • Well-defined mechanism. DSS disrupts the intestinal epithelial barrier, triggering dysbiosis, impairment of macrophage function and inflammatory responses.

      Product recommendation. DSS with a molecular weight of 36,000–50,000 is the preferred choice for this study and for the majority of inflammatory bowel disease research.

      Key finding. After 5 days of 3% (w/v) DSS treatment, colon length decreased by approximately 40%–50%. Propionate and butyrate reversed this effect, whereas macrophage depletion abolished the protective benefit, demonstrating that the anti-inflammatory action of SCFAs is macrophage-dependent.

      2. Pertussis Toxin (PTX) — A Precision Switch for GPCR Signaling Studies

      Application in the study. Propionate and butyrate are known to act through histone deacetylase inhibition or GPCR activation. To exclude involvement of the GPCR pathway, the authors pre-treated macrophages with PTX. PTX pretreatment did not affect the inhibitory effect of propionate or butyrate on TBK1 phosphorylation, providing strong evidence that SCFA regulation of the p38α–TRAF3–TBK1 axis is GPCR-independent and instead reflects direct binding to p38α.

      Why PTX?

      • Specific inhibition of Gi/o proteins. PTX ADP-ribosylates the α subunit of Gi/o proteins, preventing normal receptor coupling and irreversibly blocking Gi/o-type GPCR signaling.

      • A classical tool for pathway dissection. PTX is widely used to distinguish GPCR-dependent from GPCR-independent biological effects — the gold-standard approach for resolving receptor signal transduction.

      • Well-established protocols. Although the study did not state the PTX concentration in the main text, standard practice for comparable experiments suggests a working concentration of 100 ng/mL with 12 h pretreatment.

      Reference protocol. BMDMs and RAW264.7 cells were pre-treated with PTX for 12 h (or left untreated), co-cultured with propionate or butyrate for 2 h, then stimulated with LPS for 30 min. Cell lysates were analyzed by immunoblotting with the indicated antibodies.

      3. Multiplex Immunohistochemistry (mIHC) — A Window into the Tissue Microenvironment

      Application in the study. The authors applied multiplex fluorescent immunohistochemistry to colon tissue from ulcerative colitis patients, detecting on a single tissue section:

      • the macrophage marker CD68+;

      • signaling proteins: p38α autophosphorylation (p-p38), TRAF3 S85 phosphorylation and TBK1 phosphorylation (p-TBK1);

      • immune cell infiltration: CD3+ T cells and CD19+ B cells.

      In the sodium propionate-treated group, colonic tissue showed significantly elevated p-p38 and TRAF3 pS85, markedly reduced p-TBK1, and a clear decrease in CD3+ T cell and CD19+ B cell infiltration. mIHC was the core enabling technology for this translational component of the work.

      Why an mIHC kit?

      • Simultaneous multi-target detection. Based on tyramide signal amplification (TSA), in which HRP catalyzes deposition of a fluorophore at the antigen site to achieve signal cascade amplification, 4-, 5- or even 7-color fluorescent labeling can be achieved on a single section.

      • No species restriction. Because TSA protocols include an antibody elution step, primary antibodies from the same or different host species can be combined freely.

      • Ultra-high sensitivity. Signal amplification allows reliable detection of low-abundance targets such as phosphorylated proteins.

      • Reduced antibody consumption. Primary antibody usage is substantially lowered, with a high signal-to-noise ratio and clean background.

      • Broad sample compatibility. Suitable for FFPE paraffin sections and frozen sections.

      Summary: Three Reagents Covering One Complete Research Chain

      Together, DSS, PTX and the mIHC kit span the full experimental continuum from animal model construction to signaling pathway dissection to clinical tissue validation, making them indispensable tools for intestinal inflammation and immunology research.

      Reference

      [1] Wu Q, Shi R, Xiao L, et al. p38 MAP kinase senses short-chain fatty acids to attenuate Toll-like receptor signaling and intestinal inflammation. Sci Adv. 2026;12(28):eaef1419. doi:10.1126/sciadv.aef1419


      Contact Absin

      Absin provides antibodies, proteins, ELISA kits, cell culture, detection kits, and other research reagents. If you have any product needs, please contact us.

      Absin Bioscience Inc.

      worldwide@absin.cn
      Follow us on Facebook: Absin Bio
       
       

      Ordering Details

      Email: worldwide@absin.cn

      Thanks for your interesting of our products, we will reply to you in 1-2 working days.

      • Products
      • Resources
      • Product Application
      • Calculation Tools
      • FAQs
      • Citations
      • Electronic Documents
      • About us
      • Company Profile
      • Ordering Tools
      • Customer Support
      • Contact us
      Email: worldwide@absin.cn
      picture invalid picture invalid
      ICP:16001690 Absin Bioscience Inc.All rights reserved.